Paul Tudor Jones’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.56M | Sell |
23,851
-41,564
| -64% | -$12.7M | 0.01% | 916 |
|
|
2026
Q1 | $16.4M | Buy |
65,415
+24,745
| +61% | +$6.16M | 0.03% | 508 |
|
|
2025
Q4 | $11.2M | Buy |
+40,670
| New | +$11.1M | 0.02% | 669 |
|
|
2025
Q3 | – | Sell |
-12,508
| Closed | -$2.74M | – | 3971 |
|
|
2025
Q2 | $2.74M | Buy |
+12,508
| New | +$2.67M | 0.01% | 1449 |
|
|
2024
Q1 | – | Sell |
-54,293
| Closed | -$19.1M | – | 2850 |
|
|
2023
Q4 | $19.1M | Sell |
54,293
-512
| -0.9% | -$181K | 0.15% | 133 |
|
|
2023
Q3 | $20.6M | Buy |
54,805
+7,328
| +15% | +$2.83M | 0.21% | 67 |
|
|
2023
Q2 | $18.2M | Buy |
+47,477
| New | +$17M | 0.22% | 65 |
|
|
2023
Q1 | – | Sell |
-19,228
| Closed | -$4.53M | – | 3015 |
|
|
2022
Q4 | $4.53M | Sell |
19,228
-462
| -2% | -$109K | 0.09% | 285 |
|
|
2022
Q3 | $4.84M | Buy |
19,690
+14,865
| +308% | +$4.53M | 0.1% | 231 |
|
|
2022
Q2 | $1.46M | Buy |
+4,825
| New | +$1.57M | 0.04% | 669 |
|
|
2022
Q1 | – | Sell |
-975
| Closed | -$457K | – | 2766 |
|
|
2021
Q4 | $457K | Buy |
+975
| New | +$420K | 0.01% | 1542 |
|
|
2021
Q3 | – | Sell |
-2,381
| Closed | -$855K | – | 2848 |
|
|
2021
Q2 | $855K | Sell |
2,381
-733
| -24% | -$242K | 0.02% | 926 |
|
|
2021
Q1 | $877K | Buy |
3,114
+689
| +28% | +$197K | 0.02% | 902 |
|
|
2020
Q4 | $687K | Sell |
2,425
-2,692
| -53% | -$755K | 0.02% | 830 |
|
|
2020
Q3 | $1.41M | Buy |
+5,117
| New | +$1.35M | 0.06% | 437 |
|
|
2020
Q2 | – | Sell |
-2,154
| Closed | -$328K | – | 1451 |
|
|
2020
Q1 | $328K | Buy |
+2,154
| New | +$332K | 0.03% | 662 |
|
|
2019
Q4 | – | Sell |
-11,528
| Closed | -$1.64M | – | 1412 |
|
|
2019
Q3 | $1.64M | Buy |
+11,528
| New | +$1.59M | 0.06% | 362 |
|
|
2016
Q4 | – | Sell |
-12,557
| Closed | -$935K | – | 1631 |
|
|
2016
Q3 | $935K | Sell |
12,557
-1,443
| -10% | -$115K | 0.02% | 432 |
|
|
2016
Q2 | $1.06M | Buy |
14,000
+9,600
| +218% | +$699K | 0.02% | 429 |
|
|
2016
Q1 | $305K | Buy |
+4,400
| New | +$265K | 0.01% | 1287 |
|
|
2015
Q1 | – | Sell |
-3,800
| Closed | -$202K | – | 1638 |
|
|
2014
Q4 | $202K | Sell |
3,800
-7,797
| -67% | -$390K | 0.01% | 1275 |
|
|
2014
Q3 | $519K | Sell |
11,597
-15,113
| -57% | -$642K | 0.02% | 647 |
|
|
2014
Q2 | $1.13M | Buy |
26,710
+13,993
| +110% | +$599K | 0.04% | 175 |
|
|
2014
Q1 | $560K | Buy |
12,717
+5,717
| +82% | +$269K | 0.02% | 460 |
|
|
2013
Q4 | $343K | Sell |
7,000
-300
| -4% | -$14K | 0.02% | 805 |
|
|
2013
Q3 | $300K | Sell |
7,300
-1,900
| -21% | -$72.5K | 0.01% | 591 |
|
|
2013
Q2 | $323K | Buy |
+9,200
| New | +$303K | 0.02% | 521 |
|
Other funds holding WST
GIM
Paul Tudor Jones's WST Position: Q2 2026 in Review
Paul Tudor Jones reduced its West Pharmaceutical (WST) stake by 64% in Q2 2026, selling an estimated $12.7M and leaving 23,851 shares worth $8.56M. The position accounts for 0.01% of the portfolio, ranked #916.
Paul Tudor Jones first reported a position in WST in Q2 2013 and has held it in 27 quarters since. The position peaked at $20.6M in Q3 2023. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Paul Tudor Jones held 23,851 shares of West Pharmaceutical worth $8.56M as of Q2 2026.
- Paul Tudor Jones sold 41,564 West Pharmaceutical shares in Q2 2026, an estimated $12.7M.
- West Pharmaceutical made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #916 holding.
- Paul Tudor Jones first reported a position in West Pharmaceutical in Q2 2013 and has held it in 27 quarters since.
- Paul Tudor Jones's West Pharmaceutical position peaked at $20.6M in Q3 2023.
- 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.